Your browser doesn't support javascript.
loading
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study.
Whelan, Christopher D; Altmann, Andre; Botía, Juan A; Jahanshad, Neda; Hibar, Derrek P; Absil, Julie; Alhusaini, Saud; Alvim, Marina K M; Auvinen, Pia; Bartolini, Emanuele; Bergo, Felipe P G; Bernardes, Tauana; Blackmon, Karen; Braga, Barbara; Caligiuri, Maria Eugenia; Calvo, Anna; Carr, Sarah J; Chen, Jian; Chen, Shuai; Cherubini, Andrea; David, Philippe; Domin, Martin; Foley, Sonya; França, Wendy; Haaker, Gerrit; Isaev, Dmitry; Keller, Simon S; Kotikalapudi, Raviteja; Kowalczyk, Magdalena A; Kuzniecky, Ruben; Langner, Soenke; Lenge, Matteo; Leyden, Kelly M; Liu, Min; Loi, Richard Q; Martin, Pascal; Mascalchi, Mario; Morita, Marcia E; Pariente, Jose C; Rodríguez-Cruces, Raul; Rummel, Christian; Saavalainen, Taavi; Semmelroch, Mira K; Severino, Mariasavina; Thomas, Rhys H; Tondelli, Manuela; Tortora, Domenico; Vaudano, Anna Elisabetta; Vivash, Lucy; von Podewils, Felix.
Afiliação
  • Whelan CD; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, California, USA.
  • Altmann A; Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Botía JA; Translational Imaging Group, Centre for Medical Image Computing, University College London, London, UK.
  • Jahanshad N; Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK.
  • Hibar DP; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, California, USA.
  • Absil J; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, California, USA.
  • Alhusaini S; Department of Radiology, Hôpital Erasme, Universite Libre de Bruxelles, Brussels 1070, Belgium.
  • Alvim MKM; Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Auvinen P; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • Bartolini E; Department of Neurology, University of Campinas, Campinas, Brazil.
  • Bergo FPG; Epilepsy Center, Department of Neurology, Kuopio University, Kuopio, Finland.
  • Bernardes T; Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.
  • Blackmon K; Pediatric Neurology Unit, Children's Hospital A. Meyer-University of Florence, Italy.
  • Braga B; IRCCS Stella Maris Foundation, Pisa, Italy.
  • Caligiuri ME; Department of Neurology, University of Campinas, Campinas, Brazil.
  • Calvo A; Department of Neurology, University of Campinas, Campinas, Brazil.
  • Carr SJ; Comprehensive Epilepsy Center, Department of Neurology, New York University School of Medicine, New York, USA.
  • Chen J; Department of Physiology, Neuroscience and Behavioral Science, St. George's University, Grenada, West Indies.
  • Chen S; Department of Neurology, University of Campinas, Campinas, Brazil.
  • Cherubini A; Institute of Molecular Bioimaging and Physiology of the National Research Council (IBFM-CNR), Catanzaro, Italy.
  • David P; Magnetic Resonance Image Core Facility, IDIBAPS, Barcelona, Spain.
  • Domin M; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
  • Foley S; Department of Computer Science and Engineering, The Ohio State University, USA.
  • França W; Cognitive Science Department, Xiamen University, Xiamen, China.
  • Haaker G; Fujian Key Laboratory of the Brain-like Intelligent Systems, China.
  • Isaev D; Institute of Molecular Bioimaging and Physiology of the National Research Council (IBFM-CNR), Catanzaro, Italy.
  • Keller SS; Department of Radiology, Hôpital Erasme, Universite Libre de Bruxelles, Brussels 1070, Belgium.
  • Kotikalapudi R; Functional Imaging Unit, Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
  • Kowalczyk MA; Cardiff University Brain Research Imaging Centre, School of Psychology, Wales, UK.
  • Kuzniecky R; Department of Neurology, University of Campinas, Campinas, Brazil.
  • Langner S; Department of Neurosurgery, University Hospital, Freiburg, Germany.
  • Lenge M; Department of Neuropathology, University Hospital Erlangen, Germany.
  • Leyden KM; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, California, USA.
  • Liu M; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, UK.
  • Loi RQ; Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Martin P; Department of Diagnostic and Interventional Neuroradiology, University of Tübingen, Tübingen, Germany.
  • Mascalchi M; The Florey Institute of Neuroscience and Mental Health, Austin Campus, Melbourne, VIC, Australia.
  • Morita ME; Comprehensive Epilepsy Center, Department of Neurology, New York University School of Medicine, New York, USA.
  • Pariente JC; Functional Imaging Unit, Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
  • Rodríguez-Cruces R; Pediatric Neurology Unit, Children's Hospital A. Meyer-University of Florence, Italy.
  • Rummel C; Multimodal Imaging Laboratory, University of California San Diego, San Diego, California, USA.
  • Saavalainen T; Department of Psychiatry, University of California San Diego, San Diego, California, USA.
  • Semmelroch MK; Neuroimaging of Epilepsy Laboratory, Montreal Neurological Institute and Hospital, Mcgill University, Montreal, Quebec, Canada.
  • Severino M; Multimodal Imaging Laboratory, University of California San Diego, San Diego, California, USA.
  • Thomas RH; Department of Psychiatry, University of California San Diego, San Diego, California, USA.
  • Tondelli M; Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Tortora D; Neuroradiology Unit, Children's Hospital A. Meyer, Florence, Italy.
  • Vaudano AE; "Mario Serio" Department of Experimental and Clinical Biomedical Sciences, University of Florence, Italy.
  • Vivash L; Department of Neurology, University of Campinas, Campinas, Brazil.
  • von Podewils F; Magnetic Resonance Image Core Facility, IDIBAPS, Barcelona, Spain.
Brain ; 141(2): 391-408, 2018 02 01.
Article em En | MEDLINE | ID: mdl-29365066
Progressive functional decline in the epilepsies is largely unexplained. We formed the ENIGMA-Epilepsy consortium to understand factors that influence brain measures in epilepsy, pooling data from 24 research centres in 14 countries across Europe, North and South America, Asia, and Australia. Structural brain measures were extracted from MRI brain scans across 2149 individuals with epilepsy, divided into four epilepsy subgroups including idiopathic generalized epilepsies (n =367), mesial temporal lobe epilepsies with hippocampal sclerosis (MTLE; left, n = 415; right, n = 339), and all other epilepsies in aggregate (n = 1026), and compared to 1727 matched healthy controls. We ranked brain structures in order of greatest differences between patients and controls, by meta-analysing effect sizes across 16 subcortical and 68 cortical brain regions. We also tested effects of duration of disease, age at onset, and age-by-diagnosis interactions on structural measures. We observed widespread patterns of altered subcortical volume and reduced cortical grey matter thickness. Compared to controls, all epilepsy groups showed lower volume in the right thalamus (Cohen's d = -0.24 to -0.73; P < 1.49 × 10-4), and lower thickness in the precentral gyri bilaterally (d = -0.34 to -0.52; P < 4.31 × 10-6). Both MTLE subgroups showed profound volume reduction in the ipsilateral hippocampus (d = -1.73 to -1.91, P < 1.4 × 10-19), and lower thickness in extrahippocampal cortical regions, including the precentral and paracentral gyri, compared to controls (d = -0.36 to -0.52; P < 1.49 × 10-4). Thickness differences of the ipsilateral temporopolar, parahippocampal, entorhinal, and fusiform gyri, contralateral pars triangularis, and bilateral precuneus, superior frontal and caudal middle frontal gyri were observed in left, but not right, MTLE (d = -0.29 to -0.54; P < 1.49 × 10-4). Contrastingly, thickness differences of the ipsilateral pars opercularis, and contralateral transverse temporal gyrus, were observed in right, but not left, MTLE (d = -0.27 to -0.51; P < 1.49 × 10-4). Lower subcortical volume and cortical thickness associated with a longer duration of epilepsy in the all-epilepsies, all-other-epilepsies, and right MTLE groups (beta, b < -0.0018; P < 1.49 × 10-4). In the largest neuroimaging study of epilepsy to date, we provide information on the common epilepsies that could not be realistically acquired in any other way. Our study provides a robust ranking of brain measures that can be further targeted for study in genetic and neuropathological studies. This worldwide initiative identifies patterns of shared grey matter reduction across epilepsy syndromes, and distinctive abnormalities between epilepsy syndromes, which inform our understanding of epilepsy as a network disorder, and indicate that certain epilepsy syndromes involve more widespread structural compromise than previously assumed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Mapeamento Encefálico / Epilepsia Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Female / Humans / Male Idioma: En Revista: Brain Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Mapeamento Encefálico / Epilepsia Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Female / Humans / Male Idioma: En Revista: Brain Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos